Service Tax Additional
select a format
Recent Viewed Reports
Why Ken Reasearch?
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"
We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"
MediPoint: Inferior Vena Cava Filters-Global Analysis and Market Forecasts
Venous thromboembolism (VTE) is a potentially lethal disease consisting of two related conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). There remains a small subset of patients with absolute or relative contraindication to anticoagulation, at high risk of embolism, or prone to PE despite adequate anticoagulation. For these patients, physicians may opt to place an inferior vena cava filter (IVCF) as a therapeutic or prophylactic treatment. While historically the adoption of IVCF increased rapidly due to the introduction of retrievable devices, new clinical evidence has come to light that is likely to inhibit any significant market expansion over the coming years.
This report focuses on the market outlook for IVCF in the major regional medical device markets of North America (Canada, Mexico, and the US), Europe (France, Germany, Italy, Russia, Spain, and the UK), Asia-Pacific (APAC) (Australia, China, India, Japan, and South Korea), and South America (Brazil). The global market forecast for this technology is determined for the 15 countries covered in the report.
Key Questions Answered
What is the current and future inferior vena cava filters market outlook in the developed and emerging markets? What trends are affecting the global market?
Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
What are the unmet needs with the current generation of devices ? How will emerging technologies such as convertible and resorbable filters fulfill these unmet needs?
What is the physician perception of this technology? Which indications have been treated most successfully using inferior vena cava filters?
What are the challenges and complications that have hindered widespread adoption?
With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global inferior vena cava filters market?
Historically, the US market has accounted for the majority of the global IVCF market due to a rapid increase in prophylactic usage of filters.
Future growth in the IVCF market will be driven primarily by increasing prophylactic usage of filters in transient high-risk patients.
The development of programs ensuring filter retrieval will increase filter retrieval rates, subsequently reducing overall complication rates associated with the device
New technologies such convertible filters are intriguing as they have potential to resolve issues with earlier devices. Filters with integrated ports and lumens that can double as a central venous catheter are also seeing increased adoption.
Overview of the inferior vena cava filters market, including reimbursement trends and M&A analysis
Annualized total market revenue by type of device, procedure trends, and market outlooks by region through 2022.
Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
Pipeline analysis: Comprehensive data split across different stages of development and analysis of emerging trends in design.
Analysis of the current and future market competition in the global inferior vena cava filters market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons To Buy
The report will enable you to
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global IVCF market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global IVCF market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Track device sales in the global and inferior vena cava filters market from 2013-2022.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Related Reports 9
3 Market Access 10
3.1 Reimbursement Trends 10
3.1.1 North America 10
3.1.2 Europe 12
3.1.3 Asia-Pacific 14
3.1.4 South America 16
3.2 M&A/Key Partnerships 17
4 Unmet Needs and Market Opportunity Analysis 18
4.1 Minimizing Post-Deployment Complication Rates 18
4.2 Optimizing Retrieval Success Rates 19
4.3 Resorbable Inferior Vena Cava Filters 20
4.4 Robust Clinical Data for Prophylactic Filter Use 20
5 Competitive Assessment 22
5.1 Market Share Analysis 22
5.2 Key Companies & Product Profiles 23
5.2.1 ALN 23
5.2.2 Argon Medical Devices 26
5.2.3 B. Braun 27
5.2.4 Boston Scientific 29
5.2.5 C.R. Bard 30
5.2.6 Cook Medical 33
5.2.7 Cordis 35
5.2.8 Volcano 37
5.2.9 Other Players 39
5.3 Pipeline Products Assessment 40
5.4 Clinical Trials to Watch 41
6 Market Outlook 42
6.1 Procedure Trends 42
6.2 Global Market Drivers and Barriers 44
6.2.1 Driver: Increasing Filter Retrieval Rates 44
6.2.2 Driver: Favorable Procedural Reimbursement in the US 45
6.2.3 Driver: Increasing Number of High-Risk Patients 46
6.2.4 Barrier: Increasing Adoption of Drug Treatment 46
6.2.5 Barrier: Skepticism from Vascular Specialists 47
6.3 Market Outlooks by Segment 47
6.4 Market Outlooks by Geography 50
6.4.1 Global Overview 50
6.4.2 North America 53
6.4.3 Europe 56
6.4.4 Asia-Pacific 58
6.4.5 South America 61
7 Appendix 63
7.1 Bibliography 63
7.2 Abbreviations 69
7.3 Methodology 71
7.3.1 Overview 71
7.3.2 Coverage 71
7.3.3 Secondary Research 71
7.4 Forecasting Methodology 72
7.5 Primary Research Summary 73
7.6 About the Authors 74
7.6.1 Premdharan Meyyan, Cardiovascular Analyst, Medical Devices 74
7.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices 74
7.6.3 David Brady, Director of Operations-Market Research 75
7.6.4 Tyler Fletcher, Global Head of Medical Devices 75
7.7 About GlobalData 76
7.8 Disclaimer 76
1.2 List of Figures
Figure 1: Global Market Shares for Inferior Vena Cava Filters, by Company, 2015 22
Figure 2: US Inferior Vena Cava Filters Procedure Volume Forecast, 2013-2022 42
Figure 3: Outside of US Inferior Vena Cava Filters Procedure Volume Forecast, 2013-2022 43
Figure 4: Global Inferior Vena Cava Filters Market Forecast (USD m), by Segment, 2013-2022 47
Figure 5: Global Inferior Vena Cava Filters Market Comparison, by Segment, 2015 & 2022 49
Figure 6: Global Inferior Vena Cava Filters Market Forecast (USD m), by Region, 2013-2022 50
Figure 7: Global Inferior Vena Cava Filters Market Comparison, by Region, 2015 & 2022 52
Figure 8: North America Inferior Vena Cava Filters Market Forecast (USD m), 2013-2022 53
Figure 9: North America Inferior Vena Cava Filters Market Comparison, by Segment, 2015 & 2022 55
Figure 10: Europe Inferior Vena Cava Filters Market Forecast (USD m), 2013-2022 56
Figure 11: Europe Inferior Vena Cava Filters Market Comparison, by Segment, 2015 & 2022 57
Figure 12: Asia-Pacific Inferior Vena Cava Filters Market Forecast (USD m), 2013-2022 58
Figure 13: Asia-Pacific Inferior Vena Cava Filters Market Comparison, by Segment, 2015 & 2022 60
Figure 14: South America Inferior Vena Cava Filters Market Forecast (USD m), 2013-2022 61
Figure 15: South America Inferior Vena Cava Filters Market Comparison, by Segment, 2015 & 2022 62
Figure 16: Vascular Surgeons Survey Primary Research Participants, by Country 73
1.1 List of Tables
Table 1: Medicare Reimbursement Coding and Payments for Inferior Vena Cava Filters, 2016 12
Table 2: Key Mergers, Acquisitions, and Partnerships in Inferior Vena Cava Filters Market 17
Table 3: Trackable Adverse Event Incidences Associated with Inferior Vena Cava Filters 18
Table 4: Filter Retrieval Success Rates, by Brand (CIRSE Registry) 19
Table 5: ALN-Company SWOT Analysis 24
Table 6: ALN-Marketed Products Assessment 25
Table 7: Argon Medical Devices-Company SWOT Analysis 26
Table 8: Argon Medical Devices-Marketed Products Assessment 27
Table 9: B. Braun-Company SWOT Analysis 28
Table 10: B. Braun-Marketed Products Assessment 28
Table 11: Boston Scientific-Company SWOT Analysis 29
Table 12: Boston Scientific-Marketed Products Assessment 30
Table 13: C.R. Bard-Company SWOT Analysis 31
Table 14: C.R. Bard-Marketed Products Assessment 32
Table 15: Cook Medical-Company SWOT Analysis 33
Table 16: Cook Medical-Marketed Products Assessment 34
Table 17: Cordis (Cardinal Health)-Company SWOT Analysis 35
Table 18: Cordis-Marketed Products Assessment 36
Table 19: Volcano-Company SWOT Analysis 37
Table 20: Volcano-Marketed Products Assessment 37
Table 21: Other Players Assessment 39
Table 22: Pipeline Products Assessment 40
Table 23: Clinical Trials to Watch 41
Table 24: Filter Retrieval Initiatives to Improve Patient Follow-up 45
Table 25: Global Market Forecast for Inferior Vena Cava Filters (USD m), by Segment, 2012-2022 48
Table 26: Global Market Forecast for Inferior Vena Cava Filters (USD m), by Region, 2013-2022 51
Table 27: North America Market Forecast for Inferior Vena Cava Filters (USD m), by Segment, 2013-2022 53
Table 28: Europe Market Forecast for Inferior Vena Cava Filters (USD m), by Segment, 2013-2022 56
Table 29: Asia-Pacific Market Forecast for Inferior Vena Cava Filters (USD m), by Segment, 2013-2022 58
Table 30: South America Market Forecast for Inferior Vena Cava Filters (USD m), by Segment, 2013-2022 61
Single User License:
Corporate User License:
Argon Medical Devices